82_FR_45788 82 FR 45600 - Agency Generic Information Collection Activities; Proposed Collection; Public Comment Request

82 FR 45600 - Agency Generic Information Collection Activities; Proposed Collection; Public Comment Request

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary

Federal Register Volume 82, Issue 188 (September 29, 2017)

Page Range45600-45601
FR Document2017-20901

In compliance with the requirement of the Paperwork Reduction Act of 1995, the Office of the Secretary (OS), Department of Health and Human Services, is publishing the following summary of a proposed collection for public comment.

Federal Register, Volume 82 Issue 188 (Friday, September 29, 2017)
[Federal Register Volume 82, Number 188 (Friday, September 29, 2017)]
[Notices]
[Pages 45600-45601]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-20901]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary

[HHS-OS-0990-0281-60D]


Agency Generic Information Collection Activities; Proposed 
Collection; Public Comment Request

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with the requirement of the Paperwork Reduction 
Act of 1995, the Office of the Secretary (OS), Department of Health and 
Human Services, is publishing the following summary of a proposed 
collection for public comment.

DATES: Comments on the ICR must be received on or before November 28, 
2017.

ADDRESSES: Submit your comments to [email protected] or by calling 
(202) 795-7714.

FOR FURTHER INFORMATION CONTACT: When submitting comments or requesting 
information, please include the document identifier 0990-0281-60D and 
project title for reference, to the Report Clearance Officer, Sherrette 
Funn.

SUPPLEMENTARY INFORMATION: Interested persons are invited to send 
comments regarding this burden estimate or any other aspect of this 
collection of information, including any of the following subjects: (1) 
The necessity and utility of the proposed information collection for 
the proper performance of the agency's functions; (2) the accuracy of 
the estimated burden; (3) ways to enhance the quality, utility, and 
clarity of the information to be collected; and (4) the use of 
automated collection techniques or other forms of information 
technology to minimize the information collection burden.
    Information Collection Request Title: Prevention Communication 
Formative Research--Revision--OMB No. 0990-0281.
    Abstract: The Office of Disease Prevention and Health Promotion 
(ODPHP) is focused on developing and disseminating health information 
to the public. ODPHP faces an increasingly urgent interest in finding 
effective ways to communicate health information to America's diverse 
population. ODPHP strives to be responsive to the needs of America's 
diverse audiences while simultaneously serving all Americans across a 
range of channels, from print to new communication technologies. To 
carry out prevention information efforts, ODPHP is committed to 
conducting formative and usability research to provide guidance on the 
development and implementation of their communication and education 
efforts. The information collected will be used to improve 
communication, products, and services that support key office 
activities including: Healthy People, Dietary Guidelines for Americans, 
Physical Activity Guidelines for Americans, healthfinder.gov, and 
increasing health care quality and patient safety. ODPHP communicates 
through its Web sites (www.healthfinder.gov, www.HealthyPeople.gov, 
www.health.gov) and through other channels including social media, 
print materials, interactive training modules, and reports. Data 
collection will be qualitative and quantitative and may include in-
depth interviews, focus groups, web-based surveys, omnibus surveys, 
card sorting, and various forms of usability testing of materials and 
interactive tools to assess the public's understanding of disease 
prevention and health promotion content, responses to prototype 
materials, and barriers to effective use.
    The program is requesting a 3-year clearance.
    Likely Respondents: Respondents are likely to be either consumers 
or health professionals.

                                                         Total Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                                     Average burden/
            Data collection task                   Instrument/form name           Number of      Number responses/     response (in      Total response
                                                                                 respondents         respondent           hours)       burden (in hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
In-depth interviews.........................  Screener......................              1,500                  1              10/60                250
                                              Interview.....................                500                  1               1.00                500
Focus groups................................  Screener......................              2,925                  1              10/60              487.5

[[Page 45601]]

 
                                              Focus Group...................                975                  1               1.50            1,462.5
Intercept interviews........................  Interview.....................              5,250                  1               5/60             437.50
Cognitive testing of instruments............  Screener......................                150                  1              10/60                 25
                                              Cognitive Test................                 50                  1               2.00                100
Web-based surveys...........................  Screener......................             30,000                  1               5/60              2,500
                                              Survey........................             10,000                  1              15/60              2,500
Omnibus surveys.............................  Survey........................              2,100                  1              10/60                350
Gatekeeper reviews..........................  Review........................                325                  1              30/60              162.5
Card sorting................................  Screener......................                600                  1              10/60                100
                                              Card Sort.....................                200                  1               1.00                200
Usability and prototype testing of materials  Screener......................              1,800                  1              10/60                300
 (print and web).                             Usability Test................                600                  1               1.00                600
                                                                             ---------------------------------------------------------------------------
    Total...................................  ..............................  .................  .................  .................           9,975.00
--------------------------------------------------------------------------------------------------------------------------------------------------------


Darius Taylor,
 Paperwork Reduction Act Reports Clearance Officer, Department of 
Health and Human Services.
[FR Doc. 2017-20901 Filed 9-28-17; 8:45 am]
BILLING CODE 4150-32-P



                                                    45600                          Federal Register / Vol. 82, No. 188 / Friday, September 29, 2017 / Notices

                                                    pharmacy benefit managers, to integrate                         jamasurgery/fullarticle/2644905. Accessed               of the information to be collected; and
                                                    or avoid duplicating their educational                          August 2017.                                            (4) the use of automated collection
                                                    programs or requirements? What other                              5. New York State Department of Health,               techniques or other forms of information
                                                    steps might FDA consider to make                                Mandatory Prescriber Education. Available at            technology to minimize the information
                                                                                                                    https://www.health.ny.gov/professionals/
                                                    implementation less burdensome and                              narcotic/mandatory_prescriber_education/.
                                                                                                                                                                            collection burden.
                                                    more effective?                                                 Accessed August 2017.                                      Information Collection Request Title:
                                                                                                                                                                            Prevention Communication Formative
                                                    IV. Additional Matters for                                        Dated: September 26, 2017.
                                                                                                                                                                            Research—Revision—OMB No. 0990–
                                                    Consideration                                                   Anna K. Abram,                                          0281.
                                                      1. What other steps should FDA take                           Deputy Commissioner for Policy, Planning,                  Abstract: The Office of Disease
                                                    to operationalize the above described                           Legislation, and Analysis.                              Prevention and Health Promotion
                                                    goals?                                                          [FR Doc. 2017–20905 Filed 9–28–17; 8:45 am]             (ODPHP) is focused on developing and
                                                      2. Are there additional policy steps                          BILLING CODE 4164–01–P                                  disseminating health information to the
                                                    FDA should consider relating to the                                                                                     public. ODPHP faces an increasingly
                                                    OPSC that are not identified in this                                                                                    urgent interest in finding effective ways
                                                    notice?                                                         DEPARTMENT OF HEALTH AND                                to communicate health information to
                                                      We invite interested parties to review                        HUMAN SERVICES                                          America’s diverse population. ODPHP
                                                    these questions and submit comments to                                                                                  strives to be responsive to the needs of
                                                    the docket for the OPSC to consider. In                         Office of the Secretary
                                                                                                                                                                            America’s diverse audiences while
                                                    addition, we invite interested parties to                       [HHS–OS–0990–0281–60D]                                  simultaneously serving all Americans
                                                    submit additional policy considerations                                                                                 across a range of channels, from print to
                                                    or recommendations for actions that                             Agency Generic Information Collection                   new communication technologies. To
                                                    FDA could or should undertake to help                           Activities; Proposed Collection; Public                 carry out prevention information efforts,
                                                    the Agency better address the opioid                            Comment Request                                         ODPHP is committed to conducting
                                                    addiction crisis.                                                                                                       formative and usability research to
                                                                                                                    AGENCY:      Office of the Secretary, HHS.
                                                    V. References                                                   ACTION:      Notice.                                    provide guidance on the development
                                                                                                                                                                            and implementation of their
                                                       1. Gottlieb, Scott and J. Woodcock.
                                                                                                                    SUMMARY:   In compliance with the                       communication and education efforts.
                                                    ‘‘Marshaling FDA Benefit-Risk Expertise to
                                                    Address the Current Opioid Abuse                                requirement of the Paperwork                            The information collected will be used
                                                    Epidemic.’’ Journal of the American Medical                     Reduction Act of 1995, the Office of the                to improve communication, products,
                                                    Association. 2017;318(5):421–422.                               Secretary (OS), Department of Health                    and services that support key office
                                                    Doi:10.1001/jama.2017.9205. Available at                        and Human Services, is publishing the                   activities including: Healthy People,
                                                    http://jamanetwork.com/journals/jama/                           following summary of a proposed                         Dietary Guidelines for Americans,
                                                    fullarticle/2643333. Accessed August 2017.                      collection for public comment.                          Physical Activity Guidelines for
                                                       2. National Academies of Sciences,                                                                                   Americans, healthfinder.gov, and
                                                                                                                    DATES: Comments on the ICR must be
                                                    Engineering, and Medicine. ‘‘Pain                                                                                       increasing health care quality and
                                                    Management and the Opioid Epidemic:                             received on or before November 28,
                                                                                                                    2017.                                                   patient safety. ODPHP communicates
                                                    Balancing Societal and Individual Benefits
                                                    and Risks of Prescription Opioid Use (2017),                                                                            through its Web sites
                                                                                                                    ADDRESSES:  Submit your comments to                     (www.healthfinder.gov,
                                                    Consensus Study Report.’’ Richard J. Bonnie,                    Sherrette.Funn@hhs.gov or by calling
                                                    Morgan A. Ford, and Jonathan K. Phillips                                                                                www.HealthyPeople.gov,
                                                                                                                    (202) 795–7714.                                         www.health.gov) and through other
                                                    (eds.). Available at https://www.nap.edu/
                                                    catalog/24781/pain-management-and-the-                          FOR FURTHER INFORMATION CONTACT:                        channels including social media, print
                                                    opioid-epidemic-balancing-societal-and-                         When submitting comments or                             materials, interactive training modules,
                                                    individual. Accessed August 2017.                               requesting information, please include                  and reports. Data collection will be
                                                       3. Dowell, D., T. M. Haegerich, and R.                       the document identifier 0990–0281–60D                   qualitative and quantitative and may
                                                    Chou. ‘‘CDC Guideline for Prescribing                           and project title for reference, to the                 include in-depth interviews, focus
                                                    Opioids for Chronic Pain—United States,                         Report Clearance Officer, Sherrette
                                                    2016.’’ Item 6 in ‘‘Determining When to                                                                                 groups, web-based surveys, omnibus
                                                                                                                    Funn.                                                   surveys, card sorting, and various forms
                                                    Initiate or Continue Opioids for Chronic
                                                    Pain.’’ Morbidity and Mortality Weekly                          SUPPLEMENTARY INFORMATION:      Interested              of usability testing of materials and
                                                    Report Recommendations and Reports                              persons are invited to send comments                    interactive tools to assess the public’s
                                                    2016;65(No. RR–1):1–49. DOI: http://                            regarding this burden estimate or any                   understanding of disease prevention
                                                    dx.doi.org/10.15585/mmwr.rr6501e1.                              other aspect of this collection of                      and health promotion content,
                                                    Accessed August 2017.                                           information, including any of the                       responses to prototype materials, and
                                                       4. Bicket, M. C., J. J. Long, P. J. Pronovost,               following subjects: (1) The necessity and               barriers to effective use.
                                                    et al. ‘‘Prescription Opioid Analgesics
                                                    Commonly Unused After Surgery, A
                                                                                                                    utility of the proposed information                        The program is requesting a 3-year
                                                    Systematic Review.’’ JAMA Surgery.                              collection for the proper performance of                clearance.
                                                    Published online August 2, 2017.                                the agency’s functions; (2) the accuracy                   Likely Respondents: Respondents are
                                                    DOI:10.1001/jamasurg.2017.0831. Available                       of the estimated burden; (3) ways to                    likely to be either consumers or health
                                                    at http://jamanetwork.com/journals/                             enhance the quality, utility, and clarity               professionals.
asabaliauskas on DSKBBXCHB2PROD with NOTICES




                                                                                                             TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
                                                                                                                                                                    Number           Average burden/   Total response
                                                                                                                                           Number of
                                                          Data collection task                   Instrument/form name                                             responses/            response           burden
                                                                                                                                          respondents             respondent            (in hours)       (in hours)

                                                    In-depth interviews ...............     Screener ...............................                 1,500                     1               10/60              250
                                                                                            Interview ...............................                  500                     1                1.00              500
                                                    Focus groups ........................   Screener ...............................                 2,925                     1               10/60             487.5



                                               VerDate Sep<11>2014     18:50 Sep 28, 2017    Jkt 241001     PO 00000      Frm 00026     Fmt 4703   Sfmt 4703   E:\FR\FM\29SEN1.SGM   29SEN1


                                                                                       Federal Register / Vol. 82, No. 188 / Friday, September 29, 2017 / Notices                                                                                            45601

                                                                                                       TOTAL ESTIMATED ANNUALIZED BURDEN HOURS—Continued
                                                                                                                                                                                           Number                     Average burden/                 Total response
                                                                                                                                                        Number of
                                                          Data collection task                        Instrument/form name                                                               responses/                      response                         burden
                                                                                                                                                       respondents                       respondent                      (in hours)                     (in hours)

                                                                                                 Focus Group .........................                                    975                                  1                           1.50               1,462.5
                                                    Intercept interviews ...............         Interview ...............................                              5,250                                  1                           5/60                437.50
                                                    Cognitive testing of instru-                 Screener ...............................                                 150                                  1                          10/60                    25
                                                       ments.
                                                                                                 Cognitive Test .......................                                  50                                    1                          2.00                    100
                                                    Web-based surveys ..............             Screener ...............................                            30,000                                    1                          5/60                  2,500
                                                                                                 Survey ...................................                          10,000                                    1                         15/60                  2,500
                                                    Omnibus surveys ..................           Survey ...................................                           2,100                                    1                         10/60                    350
                                                    Gatekeeper reviews ..............            Review ..................................                              325                                    1                         30/60                  162.5
                                                    Card sorting ..........................      Screener ...............................                               600                                    1                         10/60                    100
                                                                                                 Card Sort ..............................                               200                                    1                          1.00                    200
                                                    Usability and prototype test-                Screener ...............................                             1,800                                    1                         10/60                    300
                                                      ing of materials (print and                Usability Test ........................                                600                                    1                          1.00                    600
                                                      web).

                                                         Total ...............................   ...............................................   ..............................   ..............................   ..............................          9,975.00



                                                    Darius Taylor,                                                          MD 20892, 301–594–2771, johnsonrh@                                            would constitute a clearly unwarranted
                                                    Paperwork Reduction Act Reports Clearance                               nigms.nih.gov.                                                                invasion of personal privacy.
                                                    Officer, Department of Health and Human                                 (Catalogue of Federal Domestic Assistance                                       Name of Committee: National Institute of
                                                    Services.                                                               Program Nos. 93.375, Minority Biomedical                                      Biomedical Imaging and Bioengineering
                                                    [FR Doc. 2017–20901 Filed 9–28–17; 8:45 am]                             Research Support; 93.821, Cell Biology and                                    Special Emphasis Panel; P41 BTRC
                                                    BILLING CODE 4150–32–P
                                                                                                                            Biophysics Research; 93.859, Pharmacology,                                    Application Review (2018/01).
                                                                                                                            Physiology, and Biological Chemistry                                            Date: November 15–17, 2017.
                                                                                                                            Research; 93.862, Genetics and                                                  Time: 6:00 p.m. to 1:00 p.m.
                                                                                                                            Developmental Biology Research; 93.88,                                          Agenda: To review and evaluate grant
                                                    DEPARTMENT OF HEALTH AND
                                                                                                                            Minority Access to Research Careers; 93.96,                                   applications.
                                                    HUMAN SERVICES                                                          Special Minority Initiatives; 93.859,                                           Place: Boston Hotel Buckminster, 645
                                                                                                                            Biomedical Research and Research Training,                                    Beacon Street, Boston, MA 02215.
                                                    National Institutes of Health                                           National Institutes of Health, HHS)                                             Contact Person: John P. Holden, Ph.D.,
                                                    National Institute of General Medical                                     Dated: September 25, 2017.                                                  Scientific Review Officer, National Institutes
                                                                                                                                                                                                          of Health, National Institute of Biomedical
                                                    Sciences; Notice of Closed Meeting                                      Melanie J. Pantoja,
                                                                                                                                                                                                          Imaging, and Bioengineering, Bethesda, MD
                                                                                                                            Program Analyst, Office of Federal Advisory                                   20892, (301) 496–8947, john.holden@nih.gov.
                                                      Pursuant to section 10(d) of the
                                                                                                                            Committee Policy.
                                                    Federal Advisory Committee Act, as                                                                                                                      Dated: September 25, 2017.
                                                                                                                            [FR Doc. 2017–20858 Filed 9–28–17; 8:45 am]
                                                    amended, notice is hereby given of the                                                                                                                David Clary,
                                                    following meeting.                                                      BILLING CODE 4140–01–P
                                                                                                                                                                                                          Program Analyst, Office of Federal Advisory
                                                      The meeting will be closed to the                                                                                                                   Committee Policy.
                                                    public in accordance with the
                                                    provisions set forth in sections                                        DEPARTMENT OF HEALTH AND                                                      [FR Doc. 2017–20856 Filed 9–28–17; 8:45 am]

                                                    552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,                              HUMAN SERVICES                                                                BILLING CODE 4140–01–P

                                                    as amended. The grant applications and
                                                                                                                            National Institutes of Health
                                                    the discussions could disclose
                                                                                                                                                                                                          DEPARTMENT OF HEALTH AND
                                                    confidential trade secrets or commercial                                National Institute of Biomedical                                              HUMAN SERVICES
                                                    property such as patentable material,                                   Imaging and Bioengineering; Notice of
                                                    and personal information concerning                                     Closed Meeting                                                                National Institutes of Health
                                                    individuals associated with the grant
                                                    applications, the disclosure of which                                     Pursuant to section 10(d) of the                                            National Institute on Minority Health
                                                    would constitute a clearly unwarranted                                  Federal Advisory Committee Act, as                                            and Health Disparities; Notice of
                                                    invasion of personal privacy.                                           amended, notice is hereby given of a                                          Closed Meeting
                                                      Name of Committee: National Institute of                              meeting of the National Institute of                                            Pursuant to section 10(d) of the
                                                    General Medical Sciences Special Emphasis                               Biomedical Imaging and Bioengineering                                         Federal Advisory Committee Act, as
                                                    Panel; Review of Support of Competitive                                 Special Emphasis Panel.
                                                    Research (SCORE) Award Applications.                                                                                                                  amended, notice is hereby given of the
                                                      Date: October 18, 2017.                                                 The meeting will be closed to the                                           following meeting.
                                                      Time: 2:00 p.m. to 4:00 p.m.                                          public in accordance with the                                                   The meeting will be closed to the
asabaliauskas on DSKBBXCHB2PROD with NOTICES




                                                      Agenda: To review and evaluate grant                                  provisions set forth in sections                                              public in accordance with the
                                                    applications.                                                           552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,                                    provisions set forth in sections
                                                      Place: National Institutes of Health,                                 as amended. The grant applications and                                        552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
                                                    Natcher Building, Room 3AN 18, 45 Center                                the discussions could disclose                                                as amended. The grant applications and
                                                    Drive, Bethesda, MD 20892.                                              confidential trade secrets or commercial                                      the discussions could disclose
                                                      Contact Person: Rebecca H. Johnson,
                                                    Scientific Review Officer, Office of Scientific                         property such as patentable material,                                         confidential trade secrets or commercial
                                                    Review, National Institute of General Medical                           and personal information concerning                                           property such as patentable materials,
                                                    Sciences, National Institutes of Health,                                individuals associated with the grant                                         and personal information concerning
                                                    Natcher Building, Room 3AN18C, Bethesda,                                applications, the disclosure of which                                         individuals associated with the grant


                                               VerDate Sep<11>2014       18:50 Sep 28, 2017       Jkt 241001        PO 00000        Frm 00027       Fmt 4703        Sfmt 4703       E:\FR\FM\29SEN1.SGM              29SEN1



Document Created: 2017-09-29 03:27:11
Document Modified: 2017-09-29 03:27:11
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice.
DatesComments on the ICR must be received on or before November 28, 2017.
ContactWhen submitting comments or requesting information, please include the document identifier 0990-0281-60D and project title for reference, to the Report Clearance Officer, Sherrette Funn.
FR Citation82 FR 45600 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR